研究成果

年分
作者
期刊
研究名稱
2020
Martinez FA, Serenelli M, Nicolau JC, Petrie MC, Chiang CE, Tereshchenko S, Solomon SD, Inzucchi SE, Kober L, Kosiborod MN, Ponikowski P, Sabatine MS, DeMets DL, Dutkiewicz-Piasecka M, Bengtsson O, Sjostrand M, Langkilde AM, Jhund PS, McMurray JJV.
Circulation 2020;141:100-11. (IF: 23.603)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF.
2020
Sinnaeve PR*, Schwartz GG, Wojdyla DM, Alings M, Bhatt DL, Bittner VA, Chiang CE, Flores RMC, Diaz R, Dorobantu M, Goodman SG, Jukema JW, Kim YU, Pordy R, Roe MT, Sy RG, Szarek M, White HD, Zeiher AM, Steg PG.
Eur Heart J 2020;41:2248-58. (IF: 22.673)
Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
2020
Smits PC*, Chang CC, Chevalier B, West NEJ, Gori T, Barbato E, Tarantini G, Kocka V, Achenbach S, Dudek D, Escaned J, Wlodarczak A, Abdel-Wahab M, Esposito G, Tijssen JGP, Morice MC, Onuma Y, Van Geuns RJM.
EuroIntervention 2020;16:645-53. (IF: 3.993)
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial.
2020
Su YB, Kuo MJ, Lin TY, Chien CS, Yang YP, Chou SJ, Leu HB*.
J Chin Med Assoc 2020;83:704-9. (IF: 2.170)
Cardiovascular manifestation and treatment in COVID-19.
2020
Sung SH, Chuang SY*, Liu WL, Cheng HM, Hsu PF, Pan WH*.
Int J Cardiol 2020;300:178-83. (IF:3.229)
Hyperuricemia and pulse pressure are predictive of incident heart failure in an elderly population.
2020
Sung SH, Huang CJ, Cheng HM, Huang WM, Yu WC, Chen CH*.
J Card Fail 2020;26:142-50. (IF: 3.435)
Effect of Acoustic Cardiography-guided Management on 1-year Outcomes in Patients With Acute Heart Failure.
2020
Ting CT, Chen JW, Chang MS, Yin FCP*.
Am J Physiol-Heart Circul Physiol 2020;318: H925-H936. (IF: 3.864)
Pulmonary hemodynamics and wave reflections in adults with atrial septal defects.
2020
Tsai CT, Huang WC, Teng HI, Tsai YL, Lu TM*.
Cardiovasc Diabetol 2020;19:119. (IF: 7.332)
Long term clinical impact of successful recanalization of chronic total occlusion in patients with and without type 2 diabetes mellitus.
2020
Tsai CT, Liao JN, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chao TF*, Lip GYH, Chen SA.
JAMA Netw Open 2020;3:e0233178. (IF:5.032)
Association of ischemic stroke, major bleeding, and other adverse events with Warfarin use vs non-vitamin k antagonist oral anticoagulant use in patients with atrial fibrillation with a history of intracranial hemorrhage.
2020
Tsai CT, Lu YW, Chou RH, Tsai YL, Kuo MR, Guo JY, Lu CT, Kuo CS, Huang PH*.
PLoS One 2020;15:e0233178. (IF:2.740)
Associations of antithrombotic agent use with clinical outcomes in critically ill patients with troponin I elevation in the absence of acute coronary syndrome.